10.25
price down icon0.10%   -0.010
after-market Handel nachbörslich: 10.15 -0.10 -0.98%
loading
Schlusskurs vom Vortag:
$10.26
Offen:
$10.3
24-Stunden-Volumen:
1.05M
Relative Volume:
1.75
Marktkapitalisierung:
$592.02M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
10.79
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
+3.22%
1M Leistung:
-1.91%
6M Leistung:
-49.38%
1J Leistung:
-13.65%
1-Tages-Spanne:
Value
$9.96
$10.38
1-Wochen-Bereich:
Value
$9.20
$10.38
52-Wochen-Spanne:
Value
$9.20
$21.48

Embecta Corp Stock (EMBC) Company Profile

Name
Firmenname
Embecta Corp
Name
Telefon
(862) 401-0000
Name
Adresse
1209 ORANGE STREET, WILMINGTON
Name
Mitarbeiter
2,100
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-26
Name
Neueste SEC-Einreichungen
Name
EMBC's Discussions on Twitter

Vergleichen Sie EMBC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Instruments & Supplies icon
EMBC
Embecta Corp
10.25 592.02M 1.12B 55.30M -30.30M 0.95
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
540.60 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.27 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.30 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.88 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
221.22 16.36B 2.90B 467.20M 306.90M 6.37

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Mizuho Neutral
2024-12-02 Hochstufung Morgan Stanley Underweight → Equal-Weight
2024-11-27 Hochstufung BTIG Research Neutral → Buy
2023-10-20 Eingeleitet Wolfe Research Peer Perform
2023-01-06 Herabstufung Morgan Stanley Equal-Weight → Underweight
2022-09-08 Eingeleitet BTIG Research Neutral
2022-08-01 Eingeleitet Morgan Stanley Equal-Weight
2022-06-21 Eingeleitet BofA Securities Underperform
Alle ansehen

Embecta Corp Aktie (EMBC) Neueste Nachrichten

pulisher
Jun 16, 2025

Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction - MSN

Jun 16, 2025
pulisher
Jun 12, 2025

Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 10, 2025

Transcript : Embecta Corp. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener

Jun 10, 2025
pulisher
Jun 05, 2025

InvestingPro’s bearish call on Embecta proves accurate with 48% decline By Investing.com - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 03, 2025

Embecta stock hits 52-week low at $10.26 amid market challenges By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 02, 2025

Embecta stock hits 52-week low at $10.26 amid market challenges - Investing.com Australia

Jun 02, 2025
pulisher
May 29, 2025

BofA cuts Embecta stock price target to $18 from $20 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

BofA cuts Embecta stock price target to $18 from $20 - Investing.com India

May 29, 2025
pulisher
May 28, 2025

(EMBC) Technical Data - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Embecta Corp (EMBC) Stock Price Down 6.22% on May 28 - GuruFocus

May 28, 2025
pulisher
May 27, 2025

embecta to Participate in Investor Events - The Manila Times

May 27, 2025
pulisher
May 27, 2025

embecta to Participate in Investor Events - GlobeNewswire Inc.

May 27, 2025
pulisher
May 25, 2025

Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock - Yahoo Finance

May 25, 2025
pulisher
May 24, 2025

Insider Buying: David Melcher Acquires 10,000 Shares of Embecta Corp (EMBC) - GuruFocus

May 24, 2025
pulisher
May 23, 2025

Director Makes Bold Move with Major Stock Purchase in Embecta Corporation! - TipRanks

May 23, 2025
pulisher
May 23, 2025

Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | EMBC Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Embecta (EMBC) Price Target Cut by Mizuho Amid Flat Sales Outlook | EMBC Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Embecta price target lowered to $25 from $26 at BTIG - TipRanks

May 23, 2025
pulisher
May 23, 2025

Embecta Corporation’s Strategic Transition and Financial Outlook: A Buy Rating Based on Growth Initiatives and Attractive Valuation - TipRanks

May 23, 2025
pulisher
May 23, 2025

Embecta Corp (EMBC) Shares Gap Down to $10.85 on May 22 - GuruFocus

May 23, 2025
pulisher
May 22, 2025

Embecta stock touches 52-week low at $10.82 amid market challenges - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

Embecta eyes shift from insulin delivery to broader medical supplies focus - Drug Delivery Business

May 22, 2025
pulisher
May 22, 2025

Transcript : Embecta Corp.Analyst/Investor Day - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Embecta stock touches 52-week low at $10.82 amid market challenges By Investing.com - Investing.com South Africa

May 22, 2025
pulisher
May 22, 2025

Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15 - simplywall.st

May 22, 2025
pulisher
May 22, 2025

Embecta Unveils Strategy at Analyst and Investor Day - TipRanks

May 22, 2025
pulisher
May 22, 2025

Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

Embecta Corp. Re-Affirms Earnings Guidance for the Fiscal Year 2025 - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Embecta Corp. Hosts Inaugural Analyst and Investor Day to Outline Long-Term Financial Plan and Strategic Priorities - Nasdaq

May 22, 2025
pulisher
May 22, 2025

embecta to Showcase Phased Approach for Value Creation and - GlobeNewswire

May 22, 2025
pulisher
May 21, 2025

embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.

May 21, 2025
pulisher
May 21, 2025

Cautious Outlook on Embecta Corporation Amidst Unclear Growth Catalysts and Margin Concerns - TipRanks

May 21, 2025
pulisher
May 19, 2025

Embecta Corp (EMBC) Shares Down 2.83% on May 19 - GuruFocus

May 19, 2025
pulisher
May 18, 2025

How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 16, 2025

Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - MSN

May 16, 2025
pulisher
May 15, 2025

Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply (NASDAQ:EMBC) - Seeking Alpha

May 15, 2025
pulisher
May 13, 2025

Embecta restructures again, outlines tariff costs - MedTech Dive

May 13, 2025
pulisher
May 13, 2025

Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating - marketscreener.com

May 13, 2025
pulisher
May 12, 2025

Positive Outlook for Embecta Corporation Amid Strong Financial Performance and Strategic Initiatives - TipRanks

May 12, 2025
pulisher
May 11, 2025

Cautious Optimism for Embecta Corporation Amid Challenging Environment and Hold Rating - TipRanks

May 11, 2025
pulisher
May 10, 2025

Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com

May 10, 2025
pulisher
May 10, 2025

Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com Nigeria

May 10, 2025

Finanzdaten der Embecta Corp-Aktie (EMBC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Embecta Corp-Aktie (EMBC) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Melcher David F
Director
Feb 25 '25
Buy
13.67
13,000
177,646
76,681
Morris Milton Mayo
Director
Feb 13 '25
Sale
16.38
3,100
50,783
36,133
$78.25
price up icon 0.46%
$196.98
price up icon 1.39%
medical_instruments_supplies COO
$73.02
price up icon 0.29%
$65.30
price down icon 0.05%
medical_instruments_supplies BAX
$31.13
price down icon 0.32%
medical_instruments_supplies WST
$221.22
price down icon 0.54%
Kapitalisierung:     |  Volumen (24h):